{{expand|time=2017-12-24T17:30:06+00:00}}
{{Drugbox
   | Watchedfields = changed
| verifiedrevid = 477173943
 | IUPAC_name = 1-[3-(2-dimethylaminoethyl)-1''H''-indol-5-yl]- ''N''-methyl-methanesulfonamide
 | image = Sumatriptan Structural Formula V.1.svg
 | image2 = Sumatriptan-3D-balls.png
 | alt2 = Sumatriptan molecule

<!--Clinical data-->
 | tradename = Imitrex, Imigran ,Treximet
 | Drugs.com = {{drugs.com|monograph|sumatriptan}}
 | licence_US = Sumatriptan
 | pregnancy_category = C
 | legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
 | legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
 | legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
 | legal_US     = Rx-only
 | routes_of_administration = tablet, subcutaneous injection, nasal spray

<!--Pharmacokinetic data-->
 | bioavailability = 15% (oral)/ 96% (s.c)
 | protein_bound = 14%-21%
 | metabolism = [[Monoamine_oxidase|MAO]]
 | elimination_half-life = 2.5 hours
 | excretion = 60% [[urine|urine]]; 40% [[feces|feces]]

<!--Identifiers-->
 | CASNo_Ref = {{cascite|correct|CAS}}
 | CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 103628-46-2
 | ATC_prefix = N02
 | ATC_suffix = CC01
 | PubChem = 5358
 | IUPHAR_ligand = 54
 | DrugBank_Ref = {{drugbankcite|correct|drugbank}}
 | DrugBank = DB00669
 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
 | ChemSpiderID = 5165
 | UNII_Ref = {{fdacite|correct|FDA}}
 | UNII = 8R78F6L9VO
 | KEGG_Ref = {{keggcite|correct|kegg}}
 | KEGG = D00451
 | ChEBI_Ref = {{ebicite|correct|EBI}}
 | ChEBI = 10650
 | ChEMBL_Ref = {{ebicite|correct|EBI}}
 | ChEMBL = 128

<!--Chemical data-->
 | C=14 | H=21 | N=3 | O=2 | S=1
 | molecular_weight = 295.402 g/mol
 | smiles = O=S(=O)(NC)Cc1cc2c(cc1)ncc2CCN(C)C
 | InChI = 1/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3
 | InChIKey = KQKPFRSPSRPDEB-UHFFFAOYAF
 | StdInChI_Ref = {{stdinchicite|correct|chemspider}}
 | StdInChI = 1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3
 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
 | StdInChIKey = KQKPFRSPSRPDEB-UHFFFAOYSA-N
}}

'''舒马曲坦''' （{{lang-en|Sumatriptan}}，或译为'''舒马普坦'''、'''英明格'''）是一种[[曲坦类药物|曲坦类药物]]，用于治疗[[偏頭痛|偏頭痛]]。在结构上，舒马曲坦和[[蟾毒色胺|蟾毒色胺]]、[[5-甲氧基二甲基色胺|5-甲氧基二甲基色胺]]一样是一种[[生物碱|生物碱]]——[[二甲基色胺|二甲基色胺]]（[[DMT|DMT]]）的衍生物，其特点是二甲基N-乙酰基团连在[[吲哚|吲哚]]环的5号位C上。<ref>The presence of the [[Sulfonamide_(chemistry)|sulfonamide]] group in the molecule does not make sumatriptan a "sulfa drug", since it does not have any [[anti-microbial|anti-microbial]] properties.</ref>

许多制药工厂都有生产舒马曲坦，并以不同商品名出售，比如舒马普坦（Sumatriptan）、英明格（Imigran）、Imitrex、Treximet等。

== 参考文献 ==
{{Reflist|2}}

{{抗偏头痛药}}
{{色胺}}
{{GlaxoSmithKline}}

[[Category:吲哚|Category:吲哚]]